Sfoglia per Autore
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers.
2012-01-01 Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D.
Cytokine Induced Killer cells immunotherapy overcomes the resistance to MET tyrosine kinase inhibitors in nonsmall cell lung cancer
2012-01-01 M. Todorovic; S. Corso; L. Gammaitoni; V. Leuci; G. Mesiano; L. Giraudo Diego; S. Capellero; S. Giordano; M. Aglietta; D. Sangiolo
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways
2012-01-01 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.
2012-01-01 Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D.
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features.
2013-01-01 Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma.
2013-01-01 Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives.
2013-01-01 Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.
2014-01-01 Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G.
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy
2014-01-01 Leuci V; Mesiano G; Gammaitoni L; Todorovic M; Giraudo L; Fabrizio CS; Aglietta M; Sangiolo D.
Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors.
2014-01-01 Leuci V; Mesiano G; Gammaitoni L; Aglietta M; Sangiolo D.
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma.
2014-01-01 Sangiolo D;Mesiano G;Gammaitoni L;Aglietta M;Grignani G
Recent advances in the development of breast cancer vaccines.
2014-01-01 Milani A;Sangiolo D;Aglietta M;Valabrega G
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective.
2014-01-01 Gammaitoni L;Leuci V;Mesiano G;Giraudo L;Todorovic M;Carnevale-Schianca F;Aglietta M;Sangiolo D
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells.
2015-01-01 Gammaitoni L;Giraudo L;Leuci V;Mesiano G;Cangemi M;Zaccagna A;Pisacane A;Gallo S;Carnevale-Schianca F;Aglietta M;Sangiolo D
Cytokine-induced killer cells engineered with exogenous t-cell receptors directed against melanoma antigens: Enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition
2015-01-01 Elia, Angela R; Circosta, Paola; Sangiolo, Dario; Bonini, Chiara; Gammaitoni, Loretta; Mastaglio, Sara; Genovese, Pietro; Geuna, Massimo; Avolio, Fabio; Inghirami, Giorgio; Tarella, Corrado; Cignetti, Alessandro
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives
2015-01-01 Sanlorenzo, Martina; Vujic, Igor; Moy, Adrian; Quaglino, Pietro; Fierro, Maria Teresa; Gammaitoni, Loretta; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
2015-01-01 Pignochino, Ymera; Dell'Aglio, Carmine; Inghilleri, Simona; Zorzetto, Michele; Basiricò, Marco; Capozzi, Federica; Canta, Marta; Piloni, Davide; Cemmi, Francesca; Sangiolo, Dario; Gammaitoni, Loretta; Soster, Marco; Marchiò, Serena; Pozzi, Ernesto; Morbini, Patrizia; Luisetti, Maurizio; Aglietta, Massimo; Grignani, Giovanni; Stella, Giulia M
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidences and perspectives
2015-01-01 Giraudo, Lidia; Gammaitoni, Loretta; Cangemi, Michela; Rotolo, Ramona; Aglietta, Massimo; Sangiolo, Dario
Redirectedt cells in cancer therapy
2015-01-01 Sangiolo D.
Adoptive immunotherapy against sarcomas.
2015-01-01 Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. | 2012 | Todorovic M; Mesiano G; Gammaitoni L; Leuci V; Giraudo Diego L; Cammarata C; Jordaney N; Carnevale-Schianca F; Gallo S; Fagioli F; Piacibello W; Elia AR; Pignochino Y; Dell'aglio C; Grignani G; Cignetti A; Aglietta M; Sangiolo D. | |
Cytokine Induced Killer cells immunotherapy overcomes the resistance to MET tyrosine kinase inhibitors in nonsmall cell lung cancer | 2012 | M. Todorovic; S. Corso; L. Gammaitoni; V. Leuci; G. Mesiano; L. Giraudo Diego; S. Capellero; S. Giordano; M. Aglietta; D. Sangiolo | |
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways | 2012 | Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G. | |
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. | 2012 | Mesiano G; Todorovic M; Gammaitoni L; Leuci V; Giraudo Diego L; Carnevale-Schianca F; Fagioli F; Piacibello W; Aglietta M; Sangiolo D. | |
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. | 2013 | Gammaitoni L;Giraudo L;Leuci V;Todorovic M;Mesiano G;Picciotto F;Pisacane A;Zaccagna A;Volpe MG;Gallo S;Caravelli D;Giacone E;Venesio T;Balsamo A;Pignochino Y;Grignani G;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. | 2013 | Pignochino Y;Dell'aglio C;Basirico M;Capozzi F;Soster M;Marchio S;Bruno S;Gammaitoni L;Sangiolo D;Torchiaro E;D'Ambrosio L;Fagioli F;Ferrari S;Alberghini M;Picci P;Aglietta M;Grignani G | |
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives. | 2013 | Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G | |
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. | 2014 | Sangiolo D; Mesiano G; Gammaitoni L; Leuci V; Todorovic M; Giraudo L; Cammarata C; Dell'aglio C; D'Ambrosio L; Pisacane A; Sarotto I; Miano S; Ferrero I; Carnevale-Schianca F; Pignochino Y; Sassi F; Bertotti A; Piacibello W; Fagioli F; Aglietta M; Grignani G. | |
Ex Vivo-Activated MHC-Unrestricted Immune Effectors for Cancer Adoptive Immunotherapy | 2014 | Leuci V; Mesiano G; Gammaitoni L; Todorovic M; Giraudo L; Fabrizio CS; Aglietta M; Sangiolo D. | |
Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors. | 2014 | Leuci V; Mesiano G; Gammaitoni L; Aglietta M; Sangiolo D. | |
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma. | 2014 | Sangiolo D;Mesiano G;Gammaitoni L;Aglietta M;Grignani G | |
Recent advances in the development of breast cancer vaccines. | 2014 | Milani A;Sangiolo D;Aglietta M;Valabrega G | |
Immunotherapy of cancer stem cells in solid tumors: initial findings and future prospective. | 2014 | Gammaitoni L;Leuci V;Mesiano G;Giraudo L;Todorovic M;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells. | 2015 | Gammaitoni L;Giraudo L;Leuci V;Mesiano G;Cangemi M;Zaccagna A;Pisacane A;Gallo S;Carnevale-Schianca F;Aglietta M;Sangiolo D | |
Cytokine-induced killer cells engineered with exogenous t-cell receptors directed against melanoma antigens: Enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition | 2015 | Elia, Angela R; Circosta, Paola; Sangiolo, Dario; Bonini, Chiara; Gammaitoni, Loretta; Mastaglio, Sara; Genovese, Pietro; Geuna, Massimo; Avolio, Fabio; Inghirami, Giorgio; Tarella, Corrado; Cignetti, Alessandro | |
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives | 2015 | Sanlorenzo, Martina; Vujic, Igor; Moy, Adrian; Quaglino, Pietro; Fierro, Maria Teresa; Gammaitoni, Loretta; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario | |
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma | 2015 | Pignochino, Ymera; Dell'Aglio, Carmine; Inghilleri, Simona; Zorzetto, Michele; Basiricò, Marco; Capozzi, Federica; Canta, Marta; Piloni, Davide; Cemmi, Francesca; Sangiolo, Dario; Gammaitoni, Loretta; Soster, Marco; Marchiò, Serena; Pozzi, Ernesto; Morbini, Patrizia; Luisetti, Maurizio; Aglietta, Massimo; Grignani, Giovanni; Stella, Giulia M | |
Cytokine-induced killer cells as immunotherapy for solid tumors: current evidences and perspectives | 2015 | Giraudo, Lidia; Gammaitoni, Loretta; Cangemi, Michela; Rotolo, Ramona; Aglietta, Massimo; Sangiolo, Dario | |
Redirectedt cells in cancer therapy | 2015 | Sangiolo D. | |
Adoptive immunotherapy against sarcomas. | 2015 | Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile